---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-001852"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2024-01-22T23:59:59+00:00"
generated_at: "2026-06-06T20:50:51.949729+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Perspective Therapeutics closes $89.8M combined public offering and Lantheus private placement

## Summary
- Gross proceeds: $69.0M from public offering + $20.8M from private placement = $89.8M total.
- Public offering: 156.4M shares at $0.37/sh and pre-funded warrants for 30.1M shares at $0.369/sh.
- Private placement to Lantheus: 56.3M shares at $0.37/sh for $20.8M gross.
- Proceeds to fund R&D, clinical trials, manufacturing, and potential acquisitions.
- Underwriters' option for 24.3M additional shares was exercised in full.

## SEC filing metadata
- accession: 0001437749-24-001852
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2024-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000143774924001852/0001437749-24-001852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000143774924001852/isr20240121_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-001852
- JSON: https://secwatch.observer/filing/0001437749-24-001852.json
- Plain text: https://secwatch.observer/filing/0001437749-24-001852.txt

## Key facts
- Material Agreements
  Perspective Therapeutics, Inc. entered into Underwriting Agreement with Oppenheimer & Co. Inc., as representative of the underwriters valued at approximately $69.0 million (effective 2024-01-17).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Oppenheimer & Co. Inc., as representative of the underwriters
  - Value: approximately $69.0 million
  - Effective: 2024-01-17
  source text: On January 17, 2024, Perspective Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Oppenheimer & Co. Inc., as representative of the underwriters named therein (the “Underwriters”), in connection with its previously announced underwritten public offering (the “Public Offering”) of 132,075,218 shares
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000143774924001852/0001437749-24-001852-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.